May 26, 2016 4:05 PM ET

Biotechnology

Company Overview of Corvas International, Inc.

Company Overview

As of October 2005, Corvas International, Inc. went out of business. Corvas International, Inc. develops biotherapeutics that address large medical markets, including cardiovascular disease and cancer. rNAPc2, Corvas' cardiovascular drug candidate in Phase II clinical trials, is an anticoagulant intended for the treatment of people affected by acute coronary syndromes, which include unstable angina and non-ST-segment elevation myocardial infarction. Corvas' cancer research programs are focused on the development of new biotherapies, including monoclonal antibodies and synthetic prodrugs that target serine proteases associated with the growth and spread of cancerous tumors. Corvas Internation...

3030 Science Park Road

San Diego, CA 92121

United States

55 Employees

Phone:

858-455-9800

Fax:

858-455-7895

Key Executives for Corvas International, Inc.

Corvas International, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States
3D Biomatrix Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Corvas International, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.